Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBIT: 2020-2025

Historic EBIT for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to $114.3 million.

  • Sotera Health's EBIT rose 41.93% to $114.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $371.5 million, marking a year-over-year increase of 18.13%. This contributed to the annual value of $297.6 million for FY2024, which is 7.57% up from last year.
  • As of Q3 2025, Sotera Health's EBIT stood at $114.3 million, which was up 16.92% from $97.7 million recorded in Q2 2025.
  • Sotera Health's EBIT's 5-year high stood at $114.3 million during Q3 2025, with a 5-year trough of $33.4 million in Q1 2023.
  • In the last 3 years, Sotera Health's EBIT had a median value of $76.8 million in 2024 and averaged $78.1 million.
  • Over the last 5 years, Sotera Health's EBIT had its largest YoY gain of 72.89% in 2023, and its largest YoY loss of 37.62% in 2023.
  • Quarterly analysis of 5 years shows Sotera Health's EBIT stood at $66.4 million in 2021, then fell by 9.42% to $60.2 million in 2022, then spiked by 72.89% to $104.0 million in 2023, then fell by 16.23% to $87.1 million in 2024, then skyrocketed by 41.93% to $114.3 million in 2025.
  • Its last three reported values are $114.3 million in Q3 2025, $97.7 million for Q2 2025, and $72.4 million during Q1 2025.